Skip to the content
  • Our Company
    • Leadership
    • Board of Directors
    • Scientific Advisory Board
  • Science & Innovation
    • Our Approach
    • Our Pipeline
  • Culture
  • Media
    • Resources
    • News
  • News
  • Contact
Menu
  • Our Company
    • Leadership
    • Board of Directors
    • Scientific Advisory Board
  • Science & Innovation
    • Our Approach
    • Our Pipeline
  • Culture
  • Media
    • Resources
    • News
  • News
  • Contact

Lighting the Way to Breakthrough Medicines

Delivering on the Promise of Oral Peptides

At Nimble, we're pioneering the development of oral therapies for immune-mediated diseases that mirror the effects of well-established treatments. By harnessing the power of our proven discovery engine, we're accelerating the advancement of our emerging pipeline into clinical trials.

Our Approach
Our Pipeline

PRE-HEADER

Lorem Ipsum Dolor 
Sit Amet Consectetur Adipiscing

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Vivamus sollicitudin purus non ex finibus tincidunt. Pellentesque blandit sapien sed urna convallis vehicula.
Call to Action

PIPELINE WITH PROMISE

Our Platform Accelerates The Discovery Of Oral Therapies

See Our Pipeline

Recent News

Press Release

Nimble Announces Formation of a World-Class Scientific Advisory Board

Read Press Release
Press Release

Nimble Therapeutics Expands Its Drug Discovery Capabilities To Advance Pipeline To The Clinic

Read Press Release

More To Read

Press Release
  • June 11, 2024

Nimble Announces Formation of a World-Class Scientific Advisory Board

Read Press Release
Press Release
  • April 3, 2024

Nimble Therapeutics Expands Its Drug Discovery Capabilities To Advance Pipeline To The Clinic

Read Press Release
News
  • March 20, 2024

Nimble Therapeutics Adds Peptide Drug Development Expertise to Board of Directors

Read News
View All News
  • Our Team
  • Our Pipeline
  • Partner
  • Resources
  • News
  • Careers
  • Contact
  • Our Team
  • Our Pipeline
  • Partner
  • Resources
  • News
  • Careers
  • Contact
  • CONNECT ON LINKEDIN

Copyright © 2024 Nimble Therapeutics, Inc

Nimble Therapeutics is now part of AbbVie

Read the announcment